Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics

BACKGROUND: Healthcare decisions made on the basis of insufficient evidence may potentially have ineffective or even harmful consequences. The proportion of older ages (over 65 years) in randomized controlled trials (RCTs) for severe asthma is not enough to establish whether anti-IL-5/IL-5R therapie...

Descripción completa

Detalles Bibliográficos
Autores principales: Principe, Stefania, Benfante, Alida, Calzetta, Luigino, Rogliani, Paola, Scichilone, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931205/
https://www.ncbi.nlm.nih.gov/pubmed/31890084
http://dx.doi.org/10.1016/j.waojou.2019.100081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931205/
https://www.ncbi.nlm.nih.gov/pubmed/31890084
http://dx.doi.org/10.1016/j.waojou.2019.100081

Ejemplares similares